Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 56:699-702, 2007
DOI: 10.2337/db06-1446
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Atouf, F.
Right arrow Articles by Lumelsky, N. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Atouf, F.
Right arrow Articles by Lumelsky, N. L.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Brief Report

No Evidence for Mouse Pancreatic ß-Cell Epithelial-Mesenchymal Transition In Vitro

Fouad Atouf, Cheol Hong Park, Klaus Pechhold, Malancha Ta, Yong Choi, and Nadya L. Lumelsky

From the Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health, Bethesda, Maryland

Address correspondence and reprint requests to Nadya Lumelsky, Center for Biotechnology and Innovation, National Institute of Dental and Craniofacial Research/National Institutes of Health, 45 Center Dr., Room 4An. 24J, Bethesda, MD 20892. E-mail: nadyal{at}nidcr.nih.gov

Abbreviations: EGFP; enhanced green fluorescent protein; EMT, epithelial-mesenchymal transition; FACS, fluorescence-activated cell sorting; hIPC, human islet progenitor cell; IEF, islet-enriched fraction

We used cre/loxP-based genetic lineage tracing analysis to test a previously proposed hypothesis that in vitro cultured adult pancreatic ß-cells undergo epithelial-mesenchymal transition (EMT) to generate a highly proliferative, differentiation-competent population of mesenchymal islet "progenitor" cells. Our results in the mouse that are likely to be directly relevant to the human system show that adult mouse ß-cells do not undergo EMT in vitro and that the mesenchymal cells that arise in cultures of adult pancreas are not derived from ß-cells. We argue that these cells most likely originate from expansion of mesenchymal cells integral to the heterogeneous pancreatic islet preparations. As such, these mesenchymal "progenitors" might not represent the best possible source for generation of physiologically competent ß-cells for treatment of diabetes.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
N. Billestrup and T. Otonkoski
Dedifferentiation for Replication of Human {beta}-Cells: A Division Between Mice and Men?
Diabetes, June 1, 2008; 57(6): 1457 - 1458.
[Full Text] [PDF]


Home page
DiabetesHome page
H. A. Russ, Y. Bar, P. Ravassard, and S. Efrat
In Vitro Proliferation of Cells Derived From Adult Human {beta}-Cells Revealed By Cell-Lineage Tracing
Diabetes, June 1, 2008; 57(6): 1575 - 1583.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
Y. Dor and B. Z. Stanger
Regeneration in Liver and Pancreas: Time to Cut the Umbilical Cord?
Sci. Signal., November 27, 2007; 2007(414): pe66 - pe66.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.